Author:
Kaymakcalan Zehra,Sakorafas Paul,Bose Sahana,Scesney Susanne,Xiong Limin,Hanzatian Denise Karaoglu,Salfeld Jochen,Sasso Eric H.
Subject
Immunology,Immunology and Allergy
Reference32 articles.
1. Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial;Sandborn;Gastroenterology,2001
2. Tumor necrosis factor and granuloma biology: explaining the differential infection risk of etanercept and infliximab;Wallis;Semin. Arthritis Rheum.,2005
3. Role of tumour necrosis factor (TNF) in host defence against tuberculosis: implications for immunotherapies targeting TNF;Ehlers;Ann. Rheum. Dis.,2003
4. Emerging biologic therapies in inflammatory bowel disease;Lim;Rev. Gastroenterol. Disord.,2004
5. Drug insight: different mechanisms of action of tumor necrosis factor antagonists–passive-aggressive behavior?;Rigby;Nat. Clin. Pract. Rheumatol.,2007